On the key role played by altered protein conformation in Parkinson's disease

Journal of Neural Transmission

Volumn 115, Issue 9, 2008, Pages 1285-1299

  Agnati, L F ^a,e   Baldelli, E ^a   Andreoli, N ^a   Woods, A S ^b   Vellani, V ^a   Marcellino, D ^c   Guidolin, D ^d   Fuxe, K ^c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF PADOVA   (Italy)

^e IRCCS SAN CAMILLO HOSPITAL   (Italy)

Author keywords

Disordered proteins; Parkinson's disease; Protein mosaics

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID; ION CHANNEL; MUTANT PROTEIN; TAU PROTEIN;

CELL STRUCTURE; COMPLEX FORMATION; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; LEWY BODY; NONHUMAN; PARKINSON DISEASE; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN MOSAIC; PROTEIN STRUCTURE; REVIEW; SUBSTANTIA NIGRA;

ALPHA-SYNUCLEIN; ANIMALS; BRAIN; HAZARDOUS SUBSTANCES; HUMANS; MITOCHONDRIAL DISEASES; NERVE TISSUE PROTEINS; NEURONS; PARKINSON DISEASE; PROTEIN CONFORMATION; SUBSTANTIA NIGRA; TAU PROTEINS;

EID: 50649100880     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-008-0072-1     Document Type: Review

References (94)

1. PM Abou-Sleiman MM Muqit NW Wood 2006 Expanding insights of mitochondrial dysfunction in Parkinson's disease Nat Rev Neurosci 7 3 207 219
2. LF Agnati K Fuxe 1984 New concepts on the structure of the neuronal networks: the miniaturization and hierarchical organization of the central nervous system. (Hypothesis) Biosci Rep 4 2 93 98
3. LF Agnati M Zoli E Merlo Pich 1990 Aspects of neural plasticity in the central nervous system. VII. Theoretical aspects of brain communication and computation Neurochem Int 16 479 500
4. LF Agnati P Cortelli R Pettersson 1995 The concept of trophic units in the central nervous system Prog Neurobiol 46 6 561 574
5. Agnati LF, Santarossa L, Benfenati F et al (2002) Molecular basis of learning and memory: modelling based on receptor mosaics. In: Apolloni B, Kurfes F (eds) From synapses to rules. Kluwer Academic/Plenum Publishers, New York
6. LF Agnati O Franzen S Ferré 2003 Possibile role of intramembrane receptor-receptor interactions in memory and learning via formation of long-lived heteromeric complexes: focus on motor learning in the basal ganglia J Neural Transm 65 195 222
7. Agnati LF, Santarossa L, Genedani S et al (2004) On the nested hierarchical organization of CNS: basic characteristics of neuronal molecular networks. In: Erdi P, Esposito A, Marinaro M, Scarpetta S (eds) Computational neuroscience: cortical dynamycs, lecture notes in computer sciences. Springer Berlin Heidelberg, New York
8. LF Agnati D Guidolin S Genedani 2005 How proteins come together in the plasma membrane and function in macromolecular assemblies: Focus on receptor mosaics J Mol Neurosci 26 2-3 133 154
9. LF Agnati S Genedani C Carone 2006 The concept of protein mosaics: physiological role and relevance for Prion disease Curr Proteomics 3 171 179
10. LF Agnati S Ferre S Genedani 2006 Allosteric modulation of dopamine D2 receptors by homocysteine J Proteome Res 5 11 3077 3083
11. LF Agnati D Guidolin G Leo 2007 Role of cooperativity in protein folding and protein mosaic assemblage relevance for protein conformational diseases Curr Protein Pept Sci 8 5 460 470
12. LF Agnati D Guidolin C Carone 2007 Understanding neuronal molecular networks builds on neuronal cellular network architecture Brain Res Rev 10.1016/j.brainresrev.2007.11.002
13. Agnati LF, Leo G, Genedani S et al (2007c) Structural plasticity in G-protein coupled receptors as demonstrated by the allosteric actions of homocysteine and computer-assisted analysis of disordered domains. Brain Res Rev. doi: 10.1016/j.brainresrev.2007.10.003
14. ES Alnemri 2007 HtrA2 and Parkinson's disease: think PINK? Nat Cell Biol 9 11 1227 1229
15. H Braak K Del Tredici U Rüb 2003 Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 2 197 211
16. H Braak RA de Vos J Bohl 2006 Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology Neurosci Lett 396 1 67 72
17. DE Cabin K Shimazu D Murphy 2002 Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein J Neurosci 22 20 8797 8807
18. V Campana D Sarnataro C Zurzolo 2005 The highways and byways of prion protein trafficking Trends Cell Biol 15 2 102 111
19. S Chandra G Gallardo R Fernández-Chacón 2005 Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration Cell 123 3 383 396
20. Y Cheng T LeGall CJ Oldfield 2006 Abundance of intrinsic disorder in protein associated with cardiovascular disease Biochemistry 45 10448 10460
21. L Conforti R Adalbert MP Coleman 2007 Neuronal death: where does the end begin? Trends Neurosci 30 4 159 166
22. KA Conway JC Rochet RM Bieganski 2001 Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct Science 294 5545 1346 1349
23. MR Cookson M Van der Brug 2008 Cell systems and the toxic mechanism(s) of alpha-synuclein Exp Neurol 209 1 5 11
24. J Díaz-Nido F Wandosell J Avila 2002 Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases Peptides 23 7 1323 1332
25. CM Dobson 2003 Protein folding and misfolding Nature 426 884 890
26. MW Dodson M Guo 2007 Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease Curr Opin Neurobiol 17 3 331 337
27. TJ Down RF Ambrose 2001 Syntropic ecotoxicology: a heuristic model for understanding the vulnerability of ecological systems to stress Ecosystem Health 7 4 266 283
28. W Dröge HM Schipper 2007 Oxidative stress and aberrant signaling in aging and cognitive decline Aging Cell 6 3 361 370
29. AK Dunker CJ Brown JD Lawson 2002 Intrinsic disorder and protein function Biochemistry 41 6573 6582
30. AL Fink 2006 The aggregation and fibrillation of alpha-synuclein Acc Chem Res 39 9 628 634
31. DL Fortin VM Nemani SM Voglmaier 2005 Neural activity controls the synaptic accumulation of alpha-synuclein J Neurosi 25 47 10913 10921
32. K Fuxe P Manger S Genedani 2006 The nigrostriatal DA pathway and Parkinson's disease J Neural Transm Suppl 70 71 83
33. Fuxe K, Marcellino D, Antonelli T et al (2008) The nigro-striatal DA neurons and mechanisms of their degeneration in Parkinson's disease. In: Ribak C, Swanson L, Jones T, Lariva Sahd J, Aramburo de la Hoz C (eds) Development to degeneration and regeneration of the nervous system. Oxford University Press, Oxford
34. WR Galpern AE Lang 2006 Interface between tauopathies and synucleinopathies: a tale of two proteins Ann Neurol 59 3 449 458
35. S Gandhi MM Muqit L Stanyer 2006 PINK1 protein in normal human brain and Parkinson's disease Brain 129 Pt 7 1720 1731
36. Y Gong L Chang KL Viola 2003 Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss Proc Natl Acad Sci USA 100 18 10417 10422
37. K Gunasekaran CJ Tsai S Kumar 2003 Extended disordered proteins: targeting function with less scaffold Trends Biochem Sci 28 81 85
38. C Haynes CJ Oldfield F Ji 2006 Intrinsic disorder is a common feature of hub proteins from four eukaryotic interactomes PLoS Comput Biol 2 8 e100
39. JJ Hoozemans SM Chafekar F Baas 2006 Always around, never the same: pathways of amyloid beta induced neurodegeneration throughout the pathogenic cascade of Alzheimer's disease Curr Med Chem 13 22 2599 2605
40. Jacob F (1970) La Logique du Vivant. Une Historie de l'Heredite. Gallimard, France
41. TL James H Liu NB Ulyanov 1997 Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform Proc Natl Acad Sci USA 94 10086 10091
42. JN Keller J Gee Q Ding 2002 The proteasome in brain aging Ageing Res Rev 1 2 279 293
43. K Kellings N Meyer C Mirenda 1992 Further analysis of nucleic acids in purified scrapie prion preparations by improved return refocusing gel electrophoresis J Gen Virol 73 Pt 4 1025 1029
44. T Kirino 2002 Ischemic tolerance J Cereb Blood Flow Metab 22 11 1283 1296
45. PN Lacor MC Buniel L Chang 2004 Synaptic targeting by Alzheimer's-related amyloid oligomers J Neurosci 24 10191 10200
46. MP Lambert AK Barlow BA Chromy 1998 Diffusible, nonfibrillar ligands derived from Ab1-42 are potent central nervous system neurotoxins Proc Natl Acad Sci USA 95 6448 6453
47. VM Lee BI Giasson JQ Trojanowski 2004 More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases Trends Neurosci 27 3 129 134
48. HG Lee RJ Castellani X Zhu 2005 Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective? Int J Exp Path 86 3 133 138
49. SJ Lee 2008 Origins and effects of extracellular α-synuclein: implications in Parkinson's disease J Mol Neurosci 34 17 22
50. Lee FJ, Liu F (2008) Genetic factors involved in the pathogenesis of Parkinson's disease. Brain Res Rev. doi: 10.1016/j.brainresrev.2008.02.001
51. R Linding LJ Jensen F Diella 2003 Protein disorder prediction: implications for structural proteomics Structure 11 1453 1459
52. IH Liu VN Uversky LA Munishkina 2005 Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation Glycobiology 15 12 1320 1331
53. S Mandel E Grunblatt P Riederer 2005 Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70 Ann NY Acad Sci 1053 356 375
54. LJ Martin Y Pan AC Price 2006 Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death J Neurosci 26 1 41 50
55. M Mattson 2007 Calcium and neurodegeneration Aging Cell 6 3 337 350
56. E Masliah E Rockenstein I Veinbergs 2001 Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease Proc Natl Acad Sci USA 98 21 12245 12250
57. MF McCarty 2001 Does a vegan diet reduce risk for Parkinson's disease? Med Hypotheses 57 3 318 323
58. GE Meredith GM Halliday S Totterdell 2004 A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation Parkinsonism Relat Disord 10 4 191 202
59. Mills RD, Sim CH, Mok SS et al (2008) Biochemical aspect of the neuroprotective mechanism of pten-induced kinase-1 (PINK1). J Neurochem. doi: 10.1111/j.1471 -4159.2008.05249.x
60. AP Minton 2000 Implications of macromolecular crowding for protein assembly Curr Opin Struct Biol 10 1 34 39
61. TF Outeiro J Tetzlaff 2007 Mechanisms of disease II: cellular protein quality control Semin Pediatr Neurol 14 1 15 25
62. Paleologou KE, Schmid AW, Rospigliosi CC et al (2008) Phosphorylation at S129, but not the phosphomimics S129E/D inhibits the fibrilization of alpha-synuclein. J Biol Chem. doi: 10.1074/jbc.M800747200
63. Parsonage D, Karplus PA, Poole LB (2007) Substrate specificity and redox potential of AhpC, a bacterial peroxiredoxin. Proc Natl Acad Sci USA. doi: 0.1073_pnas.0708308105
64. A Pitkänen TP Sutula 2002 Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy Lancet Neurol 1 3 173 181
65. MH Polymeropoulos C Lavedan E Leroy 1997 Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 5321 2045 2047
66. SB Prusiner 1997 Prion Diseases and the BSE Crisis Science 278 245 251
67. SB Prusiner 1998 Prions Proc Natl Acad Sci USA 95 23 13363 13383
68. P Radivojac Z Obradovic CJ Brown 2003 Prediction of boundaries between intrinsically ordered and disordered protein regions Pac Symp Biocomput 8 216 227
69. P Radivojac Z Obradovic DK Smith 2004 Protein flexibility and intrinsic disorder Protein Sci 13 1 71 80
70. A Recchia P Debetto A Negro 2004 α-Synuclein and Parkinson's disease FASEB J 18 6 617 626
71. AC Rego CR Oliveira 2003 Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases Neurochem Res 28 10 1563 1574
72. AE Roher J Baudry MO Chaney 2000 Oligomerization and fibril assembly of the amyloid-beta protein Biochim Biophys Acta 1502 31 43
73. CA Ross MA Poirier 2004 Protein aggregation and neurodegenerative disease Nat Med 10 S10 S17
74. S Seshadri A Beiser J Selhub 2002 Plasma homocysteine as a risk factor for dementia and Alzheimer's disease N Engl J Med 346 7 476 483
75. Schrödinger E (1944) What is life? The physical aspects of the living cell. Cambridge University Press, London
76. XM Shen H Li G Dryhurst 2000 Oxidative metabolites of 5-S-cysteinyldopamine inhibit the alpha-ketoglutarate dehydrogenase complex: possible relevance to the pathogenesis of Parkinson's disease J Neural Transm 107 8-9 959 978
77. M Shimoji L Zhang AS Mandir 2005 Absence of inclusion body formation in the MPTP mouse model of Parkinson's disease Brain Res Mol Brain Res 134 1 103 108
78. E Sidransky 2006 Heterozygosity for a Mendelian disorder as a risk factor for complex disease Clin Genet 70 4 275 282
79. N Stahl MA Baldwin DB Teplow 1993 Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing Biochemistry 32 1991 2002
80. A Stephan S Laroche S Davis 2001 Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits J Neurosci 21 5703 5714
81. M Stefani CM Dobson 2003 Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution J Mol Med 81 678 699
82. D Sulzer 2007 Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease Trends Neurosci 30 5 244 250
83. DJ Surmeier 2007 Calcium, ageing, and neuronal vulnerability in Parkinson's disease Lancet Neurol 6 10 933 938
84. A Szent-Gyorgyi 1977 Drive in living matter to perfect itself Synthesis 1 14 26
85. A Terman B Gustafsson UT Brunk 2006 Mitochondrial damage and intralysosomal degradation in cellular aging Mol Aspects Med 27 5-6 471 482
86. O Thibault JC Gant PW Landfield 2007 Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store Aging Cell 6 3 307 317
87. Thomas B, Beal MF (2007) Parkinson's disease. Hum Mol Genet 16(R2):R183-R194
88. MP Thomas K Chartrand A Reynolds 2007 Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson's disease J Neurochem 100 2 503 519
89. EC Toescu 2005 Normal brain ageing: models and mechanisms Philos Trans R Soc Lond B Biol Sci 360 1464 2347 2354
90. JW Unger 1998 Glial reaction in aging and Alzheimer's disease Microsc Res Tech 43 24 28
91. VN Uversky 2007 Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation Neurochem 103 1 17 37
92. EA Weathers ME Paulaitis TB Woolf 2004 Reduced amino acid alphabet is sufficient to accurately recognize intrinsically disordered protein FEBS Letters 576 348 352
93. L Yavich H Tanila S Vepsäläinen 2004 Role of alpha-synuclein in presynaptic dopamine recruitment J Neurosci 24 49 11165 11170
94. L Zecca FA Zucca H Wilms 2003 Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics Trends Neurosci 26 11 578 580